Investor

Active Biotech is developing pharmaceutical products within medical areas where the immune defense is of significant importance like neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer.

Active Biotech’s share is listed on the NASDAQ OMX Nordic Exchange (Stockholm) since 1986 and the company has approximately 14,000 shareholders.